Pharmaceutical Technology

JULY 15, 2025

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Packaging 52

Packaging Communication Hospitals Vaccines 52

Pharmaceutical Technology

JULY 23, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? July 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The acquisition includes vaccine candidates for respiratory syncytial virus and human metapneumovirus.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Communication 52

Pharmaceutical Technology

JULY 15, 2025

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Packaging 52

Packaging Communication Hospitals Vaccines 52

Pharmaceutical Technology

JULY 14, 2025

How will RFK Jr’s American dream for vaccines play out? A target action date of 28 April 2026 has been set under the Prescription Drug User Fee Act (PDUFA). Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma Formulate Faster.

FDA 52

FDA Packaging Hospitals Research Laboratories 52

Pharmaceutical Technology

JULY 14, 2025

How will RFK Jr’s American dream for vaccines play out? Robert Barrie July 14, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Broader label coverages for Pfizer and Moderna’s vaccines mean they have made in-roads into GSK’s RSV dominant market share. A decision by the FDA is expected in H1 2026.

Labelling 52

Labelling Vaccines FDA Packaging 52

Pharmaceutical Technology

JULY 9, 2025

How will RFK Jr’s American dream for vaccines play out? The financial impact of this agreement on JCR’s consolidated results for the fiscal year ending 31 March 2026 has already been included in the current earnings forecast. JUST-AAV is a proprietary platform technology that employs modified AAV vectors.

Packaging 52

Packaging Communication Hospitals Insurance 52

Pharmaceutical Technology

JULY 16, 2025

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Packaging 59

Packaging Communication Hospitals Pharmaceutical Companies 59

Pharmaceutical Technology

JUNE 11, 2025

June 11, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The company intends to introduce its inaugural product candidate into clinical trials by 2026. The company is progressing several programmes, intending to introduce its inaugural product candidate into clinical trials by 2026.

Communication 52

Communication Hospitals Packaging Insurance 52

Pharmaceutical Technology

JULY 16, 2025

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Documentation 52

Documentation FDA Communication Packaging 52

Pharmaceutical Technology

JULY 15, 2025

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Packaging 75

Packaging Communication Hospitals Vaccines 75

Pharmaceutical Technology

JULY 16, 2025

How will RFK Jr’s American dream for vaccines play out? Find out more Office of Management and Budget Director Russell Vought told reporters that the White House is on board with the substitute amendment to the rescissions package. Data Insights The gold standard of business intelligence.

Packaging 52

Packaging Communication Hospitals Insurance 52

Pharmaceutical Technology

JULY 14, 2025

How will RFK Jr’s American dream for vaccines play out? The WHO says that the vaccine offers a highly effective, long-acting alternative to daily oral pills and other shorter-acting options. The approval of Yeztugo was hailed as a historical breakthrough by HIV experts and charities. Sign up for our daily news round-up!

Vaccines 52

Vaccines Packaging Hospitals Communication 52

Pharmaceutical Technology

JULY 14, 2025

How will RFK Jr’s American dream for vaccines play out? While the CRL will delay the potential approval of UX111 to 2026, we are working with urgency to respond and resubmit.” We have been diligently responding to the recent CMC observations and our priority is to resolve them so that we can resubmit the BLA as soon as possible. “We

Communication 52

Communication Packaging Hospitals FDA 52

Pharmaceutical Technology

JULY 18, 2025

How will RFK Jr’s American dream for vaccines play out? However, the PRV program for rare pediatric diseases is at risk of expiry in September 2026, and is pending renewal. Give your business an edge with our leading industry insights.

FDA 52

FDA Packaging Communication Hospitals 52

Pharmaceutical Technology

JULY 17, 2025

How will RFK Jr’s American dream for vaccines play out? It is an advanced sterile fill-finish and packaging site supported by more than 200 employees. Give your business an edge with our leading industry insights.

Packaging 52

Packaging Communication Hospitals Insurance 52

Pharmaceutical Technology

JULY 18, 2025

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Packaging 52

Packaging Communication Hospitals Insurance 52

Pharmaceutical Technology

JULY 15, 2025

How will RFK Jr’s American dream for vaccines play out? Danish dermatology leader LEO Pharma has bought the rights to Boehringer Ingelheim’s psoriasis drug Spevigo (spesolimab) for €90m ($105m), strengthening its portfolio ahead of a possible public listing in 2026. Give your business an edge with our leading industry insights.

Packaging 52

Packaging Communication Hospitals Vaccines 52

Pharmaceutical Technology

JULY 16, 2025

How will RFK Jr’s American dream for vaccines play out? This allows for the continuous distribution of medicines that experience demand fluctuations throughout the year such as flu vaccines.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines Packaging 52

Pharmaceutical Technology

JUNE 13, 2025

Robert Barrie June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook mRESVIA is the second approved product in the US for Moderna, along with its Covid-19 vaccine Spikevax. Until now, the vaccine was licensed for the prevention of lower respiratory tract disease (LRTD) caused by RSV in adults aged 60 years and older.

Vaccines 52

Vaccines FDA Labelling Communication 52

Pharmaceutical Technology

JULY 18, 2025

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

FDA 52

FDA Communication Packaging Hospitals 52

Pharmaceutical Technology

JULY 14, 2025

How will RFK Jr’s American dream for vaccines play out? Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma Formulate Faster.

Communication 52

Communication Customer Service Packaging Hospitals 52

Pharmaceutical Technology

JULY 10, 2025

How will RFK Jr’s American dream for vaccines play out? Always looking ahead and never standing still, Indena’s plans for 2026 include additional production lines dedicated to highly potent molecules (OEB 5 and OEB 6), including reactors up to 100 litres housed in gloveboxes and high-capacity contained dryers.

Communication 52

Communication Packaging Hospitals Vaccines 52

Pharmaceutical Technology

JULY 17, 2025

How will RFK Jr’s American dream for vaccines play out? Sarepta Therapeutics is set to cut 500 jobs as part of its restructuring and pipeline prioritisation plan, which is expected to result in annual cash cost savings of $120m in 2026. Give your business an edge with our leading industry insights.

Labelling 52

Labelling Communication Packaging Hospitals 52

Pharmaceutical Technology

JUNE 25, 2025

GlobalData Healthcare June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Changes to ACIP could result in regulatory uncertainty for vaccine developers and manufacturers. Malone, an early mRNA pioneer, has made unfounded claims regarding the dangers of mRNA vaccines, which have sparked significant public backlash.

Vaccines 52

Vaccines Packaging Hospitals Communication 52

Pharmaceutical Technology

JUNE 26, 2025

The UK has confirmed its support for global vaccination by pledging £1.25bn to global vaccine group Gavi while the US will halt funding to the international organisation. The group had set a fundraising target of $11.9bn for its 2026-2030 budget. Credit: speedshutter Photography via Shutterstock.

Vaccines 59

Vaccines Packaging Communication Hospitals 59

Pharma Times

JULY 7, 2025

Preliminary results are expected in early 2026, depending on patient recruitment progress. Supported by the previous clinical demonstration of the safety profile of our innovative delivery technology and a solid pre-clinical package, we believe PST-611 holds the potential to improve both anatomical and functional features of dry AMD/GA.”

Vaccines 52

Vaccines Packaging Dosage 52

PharmTech

JULY 22, 2025

COVID-19 mRNA vaccine production platform. Image Credit: © wacomka - stock.adobe.com PMMI, The Association for Packaging and Processing Technologies, has announced some of the unique features being made available to attendees at Pack Expo Las Vegas, to be held from Sept. 29 through Oct. Press Release. Pacteon Group. Press Release.

Dosage 59

Dosage Packaging Compounding Vaccines 59

Pharmaceutical Technology

JUNE 16, 2025

However, Blincyto’s loss of exclusivity in Europe (2025) and the US (2026) is expected to significantly reduce its future sales. According to GlobalData’s analyst consensus forecast, surovatamig’s global sales are projected to reach $138 million by 2031, compared to $1.7 billion for Blincyto. Sign up for our daily news round-up!

Labelling 52

Labelling Communication Hospitals Vaccines 52

Pharmaceutical Technology

NOVEMBER 24, 2022

South African bio-pharmaceutical firm Biovac and the International Vaccine Institute (IVI) in South Korea have signed a licencing and technology transfer agreement for developing and manufacturing an oral cholera vaccine (OCV).

Vaccines 59

Vaccines Packaging 59

European Pharmaceutical Review

SEPTEMBER 22, 2023

According to a report by Research Nester, the global aseptic packaging market is projected to reach a revenue of $35 billion by 2033 and is estimated to reach a compound annual growth rate (CAGR) of 10 percent between 2023 and 2033. The post Aseptic packaging market to value $35bn by 2033 appeared first on European Pharmaceutical Review.

Packaging 105

Packaging Vaccines Compounding 105

PharmTech

JULY 23, 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines Feliza Mirasol April 30th 2024 Podcast In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Dosage 64

Dosage Vaccines Packaging FDA 64

BuzzRx

AUGUST 30, 2022

This law includes a broad package of provisions concerning healthcare, taxes, and climate change. The Inflation Reduction Act will allow the government to negotiate lower prescription drug costs for some of the highest-priced, covered drugs between 2026 and 2029 and beyond. million who received the shingles vaccine.

Vaccines 52

Vaccines Insurance Packaging Immunization 52

STAT

MAY 22, 2025

WASHINGTON — Lawmakers grilled Food and Drug Administration Commissioner Marty Makary on the agency’s new Covid-19 vaccine framework, the accidental firings of infant formula scientists, and the pace of regulatory approval for rare disease drugs at a Senate budget hearing on Thursday. 

FDA 103

FDA Packaging Vaccines 103